ICU Medical/$ICUI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ICU Medical
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Ticker
$ICUI
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
15,000
ISIN
US44930G1076
Website
ICU Medical Metrics
BasicAdvanced
$3.2B
-
-$3.83
0.88
-
Price and volume
Market cap
$3.2B
Beta
0.88
52-week high
$181.06
52-week low
$111.97
Average daily volume
245K
Financial strength
Current ratio
2.594
Quick ratio
0.87
Long term debt to equity
77.434
Total debt to equity
80.574
Interest coverage (TTM)
1.15%
Profitability
EBITDA (TTM)
334.676
Gross margin (TTM)
35.08%
Net profit margin (TTM)
-3.87%
Operating margin (TTM)
4.98%
Effective tax rate (TTM)
-133.36%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
1.79%
Return on equity (TTM)
-4.62%
Valuation
Price to revenue (TTM)
1.3
Price to book
1.59
Price to tangible book (TTM)
-17.19
Price to free cash flow (TTM)
25.919
Free cash flow yield (TTM)
3.86%
Free cash flow per share (TTM)
496.09%
Growth
Revenue change (TTM)
7.22%
Earnings per share change (TTM)
56.00%
3-year revenue growth (CAGR)
16.23%
10-year revenue growth (CAGR)
22.59%
3-year earnings per share growth (CAGR)
27.14%
10-year earnings per share growth (CAGR)
7.53%
What the Analysts think about ICU Medical
Analyst ratings (Buy, Hold, Sell) for ICU Medical stock.
Bulls say / Bears say
ICU Medical reported a 10% revenue growth on a constant currency basis in Q2 2024, reaching $581 million, driven by strong demand across all geographies and segments, particularly an 11% growth in the Consumables segment. (Investing.com)
The company has updated its full-year guidance, raising the midpoint for adjusted EBITDA and EPS, indicating confidence in sustained financial performance. (Investing.com)
ICU Medical's stock has gained over 56% year-to-date as of December 2024, reflecting strong investor confidence and market performance. (Investing.com)
The company posted a GAAP net loss of $(23.8) million in Q4 2024, wider than the $(17.1) million loss in Q4 2023, indicating ongoing profitability challenges. (StockTitan)
Insider selling activity, including the CEO selling $213,474.04 worth of stock in January 2025, may signal concerns about future performance. (Mayfield Recorder)
Analyst ratings have been mixed, with some downgrades to 'hold' in late 2024, suggesting cautious sentiment about the company's near-term prospects. (ETF Daily News)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
ICU Medical Financial Performance
Revenues and expenses
ICU Medical Earnings Performance
Company profitability
ICU Medical News
AllArticlesVideos
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·3 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·4 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ICU Medical stock?
ICU Medical (ICUI) has a market cap of $3.2B as of June 20, 2025.
What is the P/E ratio for ICU Medical stock?
The price to earnings (P/E) ratio for ICU Medical (ICUI) stock is 0 as of June 20, 2025.
Does ICU Medical stock pay dividends?
No, ICU Medical (ICUI) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next ICU Medical dividend payment date?
ICU Medical (ICUI) stock does not pay dividends to its shareholders.
What is the beta indicator for ICU Medical?
ICU Medical (ICUI) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.